From: Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer’s disease
Antibody
Inhibition of tau oligomer formation (%)
DC8E8
84
DC4R
25
dGAE56
16
DC25
12
DC144
−14
DC11
−45
MN423
−60
DC51
0